Clinical Trial Update: Double-Blind Placebo-Controlled CIN Trial [Phase 4]

View source ↗

Summary

Phase 4 double-blind, placebo-controlled trial for contrast-induced nephropathy in acute kidney injury was terminated and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Unspecified investigational drug in CIN trial

Snippet

Sponsor: University of Michigan | Conditions: Acute Kidney Injury | Phase 4 | Status: TERMINATED | Results posted: 2017-06-27